Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The update appears to be minor UI tweaks with no addition or removal of core study content (title, conditions, interventions, primary outcomes, locations, or sponsor). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:10:40.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated version to v3.2.0; removed v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T22:47:25.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated to Revision v3.1.0 and removed several specific drug-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the prior version.
    Difference
    0.4%
    Check dated 2025-09-28T19:28:09.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T07:49:45.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T01:34:37.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has added significant content related to drug safety and various pharmaceutical topics, while removing several specific drug categories and related topics, including some references to schizophrenia.
    Difference
    5%
    Check dated 2025-08-31T00:45:11.000Z thumbnail image

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.